An estimated 15.5 million adults in the U.S. reported a current ADHD diagnosis, and about half of them were prescribed medication for it in the previous year.¹ 

Medication is one part of comprehensive ADHD care, helping with focus, impulsivity, and everyday tasks. Treatment can also include cognitive behavioral therapy (CBT), ADHD-focused counseling, and practical strategies for managing time, staying organized, and navigating work and relationships.

When it comes to choosing ADHD medication, the best option depends on your age, symptoms, health history, daily routine, and how you respond to treatment. 

How ADHD Medication Works

ADHD is a neurodevelopmental condition defined by frequent inattention, hyperactivity, and/or impulsivity. It’s one of the most common childhood disorders and can continue into adulthood, with no two people experiencing it the same way.² 

Many ADHD medications work by increasing the availability of two neurotransmitters — dopamine and norepinephrine — which play a role in focus, motivation, and impulse control. 

Normally, nerve cells release these chemicals to send signals to other cells, then reabsorb them through a process called reuptake. Medication can block this reabsorption, allowing the neurotransmitters to stick around longer and making it easier to focus, manage impulses, and follow through on tasks.

Types of ADHD Medication

ADHD medications fall into several categories: 

• Stimulants. Increase the availability of dopamine and norepinephrine by blocking their reuptake or by also increasing their release. With these options, symptoms can improve within hours.³

In the U.S., stimulant medications are classified as Schedule II controlled substances because they have potential for misuse and can lead to addiction. They can be effective ADHD treatments when taken as directed, but require careful prescribing and monitoring.

• Non-stimulants. Affect brain signaling through different mechanisms. Atomoxetine increases norepinephrine availability, while medications such as guanfacine act on receptors that help regulate communication in brain circuits involved in attention and impulse control. 

Non-stimulants generally must be taken daily and take several weeks to reach their full effect.⁴  They may be prescribed when stimulants haven’t worked well, cause side effects that are hard to live with, or aren’t a good fit, for example because of a history of substance use.

• Off-label medications. Some medications approved to treat other conditions are also prescribed for ADHD when a clinician determines they may help. One example is bupropion, an antidepressant that may improve ADHD symptoms in some.⁵ 

• A newer class. Centanafadine was approved in 2026 and acts on norepinephrine, dopamine, and serotonin.⁶

Stimulant vs. Non-Stimulant ADHD Medication

The biggest practical differences come down to speed, duration, and how closely each medication is regulated.

General ADHD Medication List

Most stimulants are versions of two active ingredients, methylphenidate or amphetamine, packaged to release over different lengths of time. The brands below are common examples and not a complete list. Many have generic versions. 

Methylphenidate-Based Stimulants

• Short-acting options include methylphenidate (Ritalin) and dexmethylphenidate (Focalin).
• Extended-release options include methylphenidate (Concerta, Ritalin LA, Aptensio XR), dexmethylphenidate (Focalin XR), and serdexmethylphenidate with dexmethylphenidate (Azstarys).
• Methylphenidate also comes as an extended-release liquid (Quillivant XR), a chewable tablet (QuilliChew ER), and a skin patch (generic transdermal system).

Amphetamine-Based Stimulants

• Short-acting options include mixed amphetamine salts (Adderall), dextroamphetamine (Zenzedi), and amphetamine sulfate (Evekeo).
• Extended-release options include mixed amphetamine salts (Adderall XR, Mydayis), dextroamphetamine (Dexedrine Spansule), and lisdexamfetamine (Vyvanse).
• Amphetamine also comes as an extended-release liquid and tablet (Dyanavel XR) and an orally dissolving tablet (Adzenys XR-ODT).

Non-Stimulant ADHD Medication

• Atomoxetine (Strattera) was the first non-stimulant approved for ADHD. It’s a selective norepinephrine reuptake inhibitor approved for adults and children 6 and older.¹¹
• Viloxazine (Qelbree) gained FDA approval for adults in 2022 as the first new non-stimulant option for adults in around 20 years.¹²
• Guanfacine ER (Intuniv) and clonidine ER (Kapvay) are approved for ADHD in ages 6 to 17. Both are approved on their own and as add-ons to stimulants.^13,14

A Newer Choice: Centanafadine

Centanafadine (Simtriyo) was approved by the FDA in 2026 for adults and children ages 6 and older who meet the weight requirement.¹⁵ It blocks the reuptake of three brain chemicals: norepinephrine, dopamine, and serotonin.

Centanafadine is classified as a central nervous system (CNS) stimulant, so it carries a potential for misuse. The manufacturer expects to begin selling the medication after the Drug Enforcement Administration (DEA) assigns it a controlled-substance classification. Because centanafadine is so new as of this writing, information about how it performs in everyday clinical practice is still limited.

Off-Label Options

Off-label prescribing means using an FDA-approved medication in a way that hasn’t been specifically approved by the FDA. For ADHD, this can mean prescribing a drug developed for another condition to help manage ADHD symptoms, or prescribing an ADHD medication to an age group for which it hasn’t been approved. 

Off-label use is legal when a clinician determines it’s medically appropriate, but the amount of research supporting each use varies.

Bupropion (Wellbutrin) is one example of a medication originally approved for other uses. It treats depression and helps people quit smoking, but it can also help some adults manage ADHD symptoms. Clinicians may consider it for those who can’t tolerate stimulants, prefer not to take them, or also have depression.¹⁶

Off-label prescribing can involve medications already approved for ADHD. For example, extended-release guanfacine and clonidine are FDA-approved for ADHD in children and adolescents, but are sometimes prescribed off-label to adults. 

An off-label prescription doesn’t automatically mean a medication is experimental or inappropriate. It just means the FDA hasn’t specifically evaluated and approved that particular use. If your clinician recommends an off-label medication, ask why they think it may help, what evidence supports it, side effects to watch for, and whether your insurance is likely to cover it.

Medication for Inattentive ADHD

ADHD medications aren’t prescribed based on symptom presentation alone, but the symptoms you struggle with most can help guide treatment. 

If inattention is your primary challenge, your clinician may focus on whether a medication helps you sustain attention, organize tasks, and follow through on responsibilities. Stimulants and non-stimulants can both help with these symptoms. 

ADHD Medication Side Effects

Starting ADHD medication can take some trial and error. Awareness of common side effects can help you recognize patterns, understand what’s manageable, and know when to check in with your prescriber. 

Side effects can look overwhelming on paper. Know that many people tolerate their medication well, and adjusting a dose or switching to another option is always a possibility. 

Stimulants

• Decreased appetite
• Trouble sleeping
• Dry mouth
• Headaches
• Irritability
• Anxiety
• Nausea
• Weight loss
• Increased blood pressure and heart rate

Stimulants carry a warning about misuse, addiction, and overdose — they should always be taken as prescribed.

Non-Stimulants

• Nausea
• Dry mouth
• Decreased appetite
• Constipation
• Dizziness
• Headaches
• Drowsiness

Atomoxetine and viloxazine also carry warnings about suicidal thoughts. For atomoxetine, the warning applies to children and adolescents. For viloxazine, it applies to children and adults, with particular attention to the first months of treatment and periods after a dose change. 

What to Track and When to Call

Keep a simple log on your phone or in a notebook detailing any side effects, including when they happen and how much they affect you. For example, a headache that starts soon after taking your medication may mean something different from one that appears as the dose wears off. These patterns can help your prescriber decide whether to adjust the dose and timing or consider another medication.

Some symptoms warrant medical attention. Contact your prescriber promptly if you experience new or worsening mood changes, and seek urgent medical care for chest pain, fainting, shortness of breath, or a racing heartbeat at rest. 

If you have thoughts of harming yourself, call or text the 988 Suicide & Crisis Lifeline for support. If you’re in immediate danger or experiencing a medical emergency, call 911.

Starting ADHD Medication: What to Expect

Everything begins with an evaluation. A psychiatric provider reviews your symptoms, history, and goals to confirm the diagnosis and identify anything else that might be contributing to your specific challenges. 

Doses start low and adjust gradually. Expect a few check-ins before you settle on the right dose. Atomoxetine, for example, is often raised after a few days and can be adjusted again after two to four weeks. Adult viloxazine doses are often adjusted in weekly steps.

Refine your treatment plan at scheduled check-ins. Bring your notes and be open about whether something isn’t working. Switching doses, formulations, or medications is common until you find the right fit. 

Therapy builds skills alongside medication. Cognitive behavioral therapy (CBT) and other structured approaches can help you develop practical strategies around planning, organization, and follow-through. Therapy can be helpful on its own or alongside medication, depending on your needs and preferences.

ADHD Medication for Adults

If you’re an adult considering medication for the first time, these are some of the most important things to raise with your prescriber.

Review your heart health. 

Stimulants and atomoxetine can raise blood pressure and heart rate. Share any heart conditions, relevant family history, or other concerns, and ask how your vital signs will be monitored during treatment.

Share your full mental health picture. 

Anxiety, depression, sleep problems, and bipolar disorder can affect treatment decisions. Be open about your symptoms and any medications you take.

Plan around your day. 

Think about when you need the most support, from work and meetings to evening responsibilities. Your prescriber can help you choose a medication and dosing schedule that fits your routine. 

Timing matters for sleep, too. For example, lisdexamfetamine is generally taken in the morning because later doses can cause insomnia.¹⁷

Take stimulants only as prescribed. 

Never share them, even with someone who also has ADHD. Misuse can lead to addiction or overdose, and combining stimulants with alcohol or other substances can increase risks.

Raise pregnancy plans early. 

If you’re pregnant, planning a pregnancy, or breastfeeding, mention it at your first appointment so it can factor into the choice.

Adult-specific guidance is on the horizon. 

The first U.S. guidelines for diagnosing and treating ADHD in adults entered final review in August 2026, with publication expected later in the year.¹⁸

There’s no single way to treat ADHD, and that’s a good thing. With multiple evidence-based paths available, you have room to find what works for you. Talk with your provider about your goals, whether that’s getting through the workday with less frustration, keeping up with responsibilities, or feeling more present in your relationships. 

Medication, therapy, and other forms of support can work together, giving you more tools to build on your strengths and make progress toward the changes you want to see.

At Rivia Mind, our psychiatrists and psychiatric nurse practitioners consider your biology, circumstances, and treatment goals before recommending a medication. We’re in-network with nearly all national and regional insurance plans. Contact us to get started.

References

1. Powers Health. About 6% of U.S. Adults Have ADHD, Drug Shortages Are Affecting Treatment.
2. National Institute of Mental Health. Attention-Deficit/Hyperactivity Disorder (ADHD)
3. National Library of Medicine. Methylphenidate.
4. National Library of Medicine. Atomoxetine.
5. Verbeeck W, Bekkering GE, Van den Noortgate W, Kramers C. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2017, Issue 10. Art. No.: CD009504. DOI: 10.1002/14651858.CD009504.pub2.
6. American Psychiatric Association. FDA Approves Centanafadine for ADHD. 
7. Cleveland Clinic. ADHD Medications. 
8. Drugs.com. Schedule II (2) Drugs. 
9. Child Mind Institute. What Are Non-Stimulant Medications for ADHD?
10. Kolar, D., Keller, A., Golfinopoulos, M., Cumyn, L., Syer, C., & Hechtman, L. (2008). Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatric disease and treatment, 4(2), 389–403. https://doi.org/10.2147/ndt.s6985
11. National Library of Medicine. Atomoxetine. 
12. BioSpace. Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults.
13. Drugs.com. Guanfacine.
14. Drugs.com. Clonidine Extended Release Tablets.
15. Food and Drug Administration. SIMTRIYO. 
16. National Alliance on Mental Illness. Bupropion (Wellbutrin)
17. Drugs.com. Vyvanse.
18. American Professional Society of ADHD and Related Disorders. APSARD announces launch of final review stage for U.S. Adult ADHD Guidelines.